Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine

被引：0
|
作者：
Diep, John K. [1 ,2 ]
Lingerfelt, Mary A. [3 ]
Ekins, Sean [3 ]
Rao, Gauri G. [1 ,2 ]
机构：
[1] UNC, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] SUNY Buffalo, Buffalo, NY USA
[3] Collaborat Pharmaceut Inc, Raleigh, NC USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-055
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [41] Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys
    Patrick M. Glassman
    Yang Chen
    Joseph P. Balthasar
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 : 527 - 540
  • [42] Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys
    Glassman, Patrick M.
    Chen, Yang
    Balthasar, Joseph P.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 (05) : 527 - 540
  • [43] Determination of the rat tissue partitioning of endotoxin in vitro for physiologically-based pharmacokinetic (PBPK) modeling
    Ross, IA
    Sapienza, PP
    Hanes, DE
    Johnson, W
    Kim, CS
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 2004, 24 (03) : 177 - 181
  • [44] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL TO CHARACTERIZE ORGAN DISTRIBUTION OF BACTERIOPHAGE (PHAGE) IN PRECLINICAL MOUSE STUDIES.
    Hanafin, P.
    Parambi, R.
    Nang, S.
    Lin, Y.
    Wang, J.
    Chen, K.
    Chang, R. Yoon Kyung
    Chan, H.
    Li, J.
    Rao, G.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S23 - S23
  • [45] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR SIMULATION OF NALOXEGOL PHARMACOKINETICS AND DRUG-DRUG INTERACTION (DDI) POTENTIAL
    Zhou, D.
    Bui, K.
    Sostek, M.
    Al-Huniti, N.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S53 - S53
  • [46] Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats
    Sweeney, Lisa M.
    MacCalman, Laura
    Haber, Lynne T.
    Kuempel, Eileen D.
    Lang Tran, C.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 73 (01) : 151 - 163
  • [47] Development of a Physiologically-Based Pharmacokinetic (PBPK) Model of Nebulized Hydroxychloroquine for Pulmonary Delivery to COVID-19 Patients
    Idkaidek, Nasir
    Hawari, Feras
    Dodin, Yasmeen
    Obeidat, Nour
    [J]. DRUG RESEARCH, 2021, 71 (05) : 250 - 256
  • [48] Utility of Physiologically-Based Pharmacokinetic Model (PBPK) for Prediction of Effects of Renal Impairment: A Learn-Confirm Paradigm
    Xu, Christine
    Kanamaluru, Vanaja
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S92 - S92
  • [49] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR FLUORIDE UPTAKE BY BONE
    RAO, HV
    BELILES, RP
    WHITFORD, GM
    TURNER, CH
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 22 (01) : 30 - 42
  • [50] The development of a stochastic physiologically-based pharmacokinetic model for lead
    Beck, BD
    Mattuck, RL
    Bowers, TS
    Cohen, JT
    O'Flaherty, E
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2001, 274 (1-3) : 15 - 19
12345